Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2010-10-13
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Boronic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Forkhead Transcription Factors, http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Intracellular Signaling Peptides..., http://linkedlifedata.com/resource/pubmed/chemical/MTOR protein, human, http://linkedlifedata.com/resource/pubmed/chemical/NVP BEZ235, http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Pyrazines, http://linkedlifedata.com/resource/pubmed/chemical/Quinolines, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/TOR Serine-Threonine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Whn protein, http://linkedlifedata.com/resource/pubmed/chemical/bortezomib, http://linkedlifedata.com/resource/pubmed/chemical/mTOR protein, mouse
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1476-5551
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1781-4
pubmed:dateRevised
2011-10-3
pubmed:meshHeading
pubmed-meshheading:20703254-Animals, pubmed-meshheading:20703254-Antineoplastic Agents, pubmed-meshheading:20703254-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:20703254-Apoptosis, pubmed-meshheading:20703254-Blotting, Western, pubmed-meshheading:20703254-Boronic Acids, pubmed-meshheading:20703254-Cell Proliferation, pubmed-meshheading:20703254-Female, pubmed-meshheading:20703254-Forkhead Transcription Factors, pubmed-meshheading:20703254-Humans, pubmed-meshheading:20703254-Imidazoles, pubmed-meshheading:20703254-Intracellular Signaling Peptides and Proteins, pubmed-meshheading:20703254-Lymphoma, Follicular, pubmed-meshheading:20703254-Mice, pubmed-meshheading:20703254-Mice, Nude, pubmed-meshheading:20703254-Phosphatidylinositol 3-Kinases, pubmed-meshheading:20703254-Protein Kinase Inhibitors, pubmed-meshheading:20703254-Protein-Serine-Threonine Kinases, pubmed-meshheading:20703254-Pyrazines, pubmed-meshheading:20703254-Quinolines, pubmed-meshheading:20703254-RNA, Messenger, pubmed-meshheading:20703254-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:20703254-TOR Serine-Threonine Kinases, pubmed-meshheading:20703254-Tumor Cells, Cultured, pubmed-meshheading:20703254-Xenograft Model Antitumor Assays
pubmed:year
2010
pubmed:articleTitle
The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma.
pubmed:publicationType
Letter, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural